NCT00563641 Very Early Surfactant and NCPAP for Premature Infants With RDS Status COMPLETED Phase PHASE3
NCT00562887 Dose Ranging Study Comparing the Efficacy, Safety and Pharmacokinetics of Intravenous Infusions of ABT-874 vs Placebo in Subjects With Active Crohn's Disease Status TERMINATED Phase PHASE2
NCT00555204 Safety and Efficacy Study of ABT-089 in Adults With Mild to Moderate Alzheimer's Disease Status TERMINATED Phase PHASE2
NCT00554385 A Safety and Tolerability Study of ABT-089 in Children With Attention-Deficit/Hyperactivity Disorder (ADHD) Status TERMINATED Phase PHASE2
NCT00538902 Safety and Efficacy Study of Adalimumab in Adult Chinese Rheumatoid Arthritis Subjects Treated With Methotrexate Status COMPLETED Phase PHASE2/PHASE3
NCT00537979 Efficacy and Safety of 6 Months Treatment With Paricalcitol Injection or Oral in Patients With Secondary Hyperparathyroidism on Dialysis Status COMPLETED Phase PHASE4
NCT00513370 A Canadian Open-Label Access Program to Evaluate Adalimumab When Added to Inadequate Therapy for the Treatment of Psoriasis Status COMPLETED Phase PHASE3
NCT00512863 A Dose-Finding Study to Evaluate the Safety, Efficacy and Pharmacokinetics of Adalimumab in Subjects With Refractory Asthma Status WITHDRAWN Phase PHASE2
NCT00502372 Effect of an Oral Supplement Enriched in Amino Acids and the Leucine Metabolite B-hydroxy B-methylbutyrate (HMB) Status TERMINATED Phase PHASE1
NCT00491530 A Year 2, Safety Extension Study of the Combination of ABT-335 and Statin Therapy for Subjects With Mixed Dyslipidemia Status COMPLETED Phase PHASE3
NCT00481013 Valproic Acid in Ambulant Adults With Spinal Muscular Atrophy Status COMPLETED Phase PHASE2
NCT00478660 An Open-Label Study to Evaluate the Response to Adalimumab in Patients With Active Ankylosing Spondylitis Who Have Failed Standard Therapy or TNF-Alpha Inhibitors (RHAPSODY) Status COMPLETED Phase PHASE3
NCT00465088 An Open-Label Study to Compare the Lipid Effects of Niacin ER and Simvastatin (NS) to Atorvastatin in Subjects With Hyperlipidemia or Mixed Dyslipidemia (SUPREME) Status COMPLETED Phase PHASE3
NCT00448383 A Study to Assess the Safety and Efficacy of Adalimumab When Added to Inadequate Standard Anti-Rheumatic Therapy in Patients With Active Rheumatoid Arthritis Status COMPLETED Phase PHASE3
NCT00445939 A Study of Adalimumab for the Induction of Clinical Remission in Japanese Subjects With Crohn's Disease Status COMPLETED Phase PHASE2/PHASE3
NCT00445432 A Study of Adalimumab for the Maintenance of Clinical Remission in Japanese Subjects With Crohn's Disease Status COMPLETED Phase PHASE2/PHASE3
NCT00439296 ABT-751 With Chemotherapy for Relapsed Pediatric ALL Status TERMINATED Phase PHASE1/PHASE2